Skip to contentS
SeaStar Medical Holding Corp
S
ICUCWSeaStar Medical Holding Corp Q1 2026 · 10-Q
Revenue$495.00K$495.00K+68.9% vs Q1 2025 Net Income-$3.52M-$3.52MN/M vs Q1 2025 EPS, diluted—
Gross Profit$449,000+53.2% Operating Income-$3,603,000N/M The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
SeaStar Medical Holding Corp · CIK 1831868 · Engraved from SEC EDGAR
Operating Cash Flow-$2,761,000N/M Margins · derivedGross margin90.7%−9.3 pt vs Q1 2025
Operating margin-727.9%+576.6 pt vs Q1 2025
Net margin-711.3%+576.1 pt vs Q1 2025
ended Mar 31, 2026 · filed May 13, 2026 · 43 d after period end